ALG1 antibody (C-Term)
Quick Overview for ALG1 antibody (C-Term) (ABIN2783688)
Target
See all ALG1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Sequence
- VKHEENGLVF EDSEELAAQL QMLFSNFPDP AGKLNQFRKN LRESQQLRWD
-
Predicted Reactivity
- Cow: 86%, Dog: 93%, Guinea Pig: 92%, Human: 100%, Mouse: 86%, Rabbit: 86%, Rat: 92%
-
Characteristics
- This is a rabbit polyclonal antibody against ALG1. It was validated on Western Blot.
-
Purification
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the C-terminal region of human ALG1
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
-
: "A severe human metabolic disease caused by deficiency of the endoplasmatic mannosyltransferase hALG11 leads to congenital disorder of glycosylation-Ip." in: Human molecular genetics, Vol. 19, Issue 8, pp. 1413-24, (2010) (PubMed).
-
-
- ALG1 (Chitobiosyldiphosphodolichol beta-Mannosyltransferase (ALG1))
-
Alternative Name
- ALG1
-
Background
-
The enzyme encoded by this gene catalyzes the first mannosylation step in the biosynthesis of lipid-linked oligosaccharides. This gene is mutated in congenital disorder of glycosylation type Ik.
Alias Symbols: HMT1, MT-1, CDG1K, HMAT1, HMT-1, Mat-1, hMat-1
Protein Size: 353 -
Molecular Weight
- 38 kDa
-
Gene ID
- 56052
-
NCBI Accession
- NM_019109, NP_061982
-
UniProt
- B4DP08
Target
-